Biohybrid M13 phage backpacks for active blood–brain barrier traversal and precision central nervous system leukemia treatment
Wei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong · 2026
Read Biohybrid M13 phage backpacks for active blood–brain barrier traversal and precision central nervous system leukemia treatment by Wei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579763.txt.
Description
Wei Wu and co-authors built a virus based carrier in 2026 to smuggle a leukemia drug across the blood brain barrier. Leukemia in the brain is hard to treat because that barrier blocks most drugs, leading to relapse and poor outcomes.
Their carrier uses a long, thin bacterial virus fitted with guides that home to the barrier and cross it. Riding on it is a backpack: a fatty packet wrapped in leukemia cell membrane, loaded with a standard drug, so it homes to leukemia cells. A linker that snaps only in spinal fluid releases the packet. In cell and mouse tests, the system crossed the barrier, killed leukemia cells, and stretched survival from twenty-nine to forty days.
Catalog record
| CREATOR | Wei Wu, Cheng-Ling Zhang, Yu-Ling Yang, Xiaoyuan Chen, Xi Zhang, Xue Dong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |